A researcher analyzes data visualizations on a digital display, highlighting insights related to causal learning.

DMC Best Practices: What Biotechs and Sponsors Should Know  

1 minute read

Published: August 5th, 2025

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise. 

Speakers:
  • Lucy Clark, Statistics Manager
  • Lisa Gibbons, Senior Statistician
  • Matt George (Moderator), Senior Statistician
Learning Points :
  • Share best practices for establishing and running an effective Data Monitoring Committee
  • Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
  • Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials.
Complete the form below to access the recording and slides:

Related articles

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

July 21st, 2026 1 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many ...